The Expression of the EGF Receptor Family and Their Ligands in Human Medulloblastomas

V. P. Collins,K. Ichimura,L. Liu

DOI: https://doi.org/10.1046/j.1365-2990.2002.39286_24.x

2002-01-01

Neuropathology and Applied Neurobiology

Abstract:Introduction: Little is known about the molecular processes behind the development of medulloblastomas. While many chromosomal abnormalities have been more or less consistently observed, only a few cellular pathways have been identified as being targeted. These include the Hedgehog/patched signalling pathway (involving PTCH, PTCH2, SSH and SMOH) and the Wnt signalling pathway (involving APC, and β‐catenin). Amplification of N‐myc is associated with a bad prognosis.Material and methods: We examined the expression of the Epidermal Growth Factor Receptor family and nine of their ligands in a series of 48 medulloblastomas and supratentorial primitive neuroectodermal tumours (PNETs) by quantitative RT‐PCR, Western blot and immunocytochemistry.Results: The most striking finding was the high levels of expression of erbB4 transcript – in some cases greater that 250 times that found in normal cerebellum. ErbB4 transcript levels greater than 10 times that of cerebellum were seen in 73% of the series. ErbB2 and erbB3 transcript levels exceeding 10 times that of cerebellum were seen in 35% of cases. Only two cases had overexpression of EGFR/erbB1 at these levels. Ligands (Epiregulin/Betacellulin/NDF_/NDF_1/NDF_2) for erbB4 were coexpressed in 74% (26/35) of the cases with high erbB4 expression. Only one case showed no expression of erbB4 and its ligands.Conclusions: The findings suggest that various forms of autocrine, paracrine, and juxtacrine stimulation through these receptors may contribute to the malignant phenotype of medulloblastomas.